Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 38

1.

Impaired function of fibroblast growth factor 23 / Klotho protein axis in prediabetes and diabetes mellitus: Promising predictor of cardiovascular risk.

Berezin AE, Berezin AA.

Diabetes Metab Syndr. 2019 Jul - Aug;13(4):2549-2556. doi: 10.1016/j.dsx.2019.07.018. Epub 2019 Jul 9. Review.

PMID:
31405675
2.

Prognostication of clinical outcomes in diabetes mellitus: Emerging role of cardiac biomarkers.

Berezin AE.

Diabetes Metab Syndr. 2019 Mar - Apr;13(2):995-1003. doi: 10.1016/j.dsx.2019.01.018. Epub 2019 Jan 18. Review.

PMID:
31336558
3.

Altered signature of apoptotic endothelial cell-derived microvesicles predicts chronic heart failure phenotypes.

Berezin AE, Kremzer AA, Samura TA, Berezina TA.

Biomark Med. 2019 Jun;13(9):737-750. doi: 10.2217/bmm-2018-0449. Epub 2019 Jun 3.

PMID:
31157550
4.

Is serum uric acid a pretty accurate prognostic predictor of ST elevated acute coronary syndrome?

Berezin AE.

Int J Cardiol. 2018 Mar 1;254:49. doi: 10.1016/j.ijcard.2017.05.113. Epub 2018 Jan 28. No abstract available.

PMID:
29407128
5.

Circulating Biomarkers in Heart Failure.

Berezin AE.

Adv Exp Med Biol. 2018;1067:89-108. doi: 10.1007/5584_2017_140. Review.

PMID:
29392578
6.

The signature of circulating microparticles in heart failure patients with metabolic syndrome.

Berezin AE, Kremzer A, Berezina T, Martovitskaya Y.

J Circ Biomark. 2016 Nov 10;5:1849454416663659. doi: 10.1177/1849454416663659. eCollection 2016 Jan-Dec.

7.

Microparticles in Chronic Heart Failure.

Berezin AE.

Adv Clin Chem. 2017;81:1-41. doi: 10.1016/bs.acc.2017.01.001. Epub 2017 Feb 15. Review.

PMID:
28629587
8.

Are inflammatory cytokines and angiogenic factors a predictive biomarker of diabetes retinopathy?

Berezin AE.

Diabetes Metab Syndr. 2017 Dec;11 Suppl 2:S735-S736. doi: 10.1016/j.dsx.2017.05.007. Epub 2017 May 17. No abstract available.

PMID:
28545909
9.

Cardiac biomarkers in diabetes mellitus: New dawn for risk stratification?

Berezin AE.

Diabetes Metab Syndr. 2017 Nov;11 Suppl 1:S201-S208. doi: 10.1016/j.dsx.2016.12.032. Epub 2016 Dec 13. Review.

PMID:
28011232
10.

An association of serum vistafin level and number of circulating endothelial progenitor cells in type 2 diabetes mellitus patients.

Berezin AE, Samura TA, Kremzer AA, Berezina TA, Martovitskaya YV, Gromenko EA.

Diabetes Metab Syndr. 2016 Oct - Dec;10(4):205-212. doi: 10.1016/j.dsx.2016.06.008. Epub 2016 Jun 8.

PMID:
27377688
11.

Biomarkers for cardiovascular risk in patients with diabetes.

Berezin AE.

Heart. 2016 Dec 15;102(24):1939-1941. doi: 10.1136/heartjnl-2016-310197. Epub 2016 Sep 12. No abstract available.

PMID:
27619331
12.

Endothelial progenitor cells dysfunction and impaired tissue reparation: The missed link in diabetes mellitus development.

Berezin AE.

Diabetes Metab Syndr. 2017 Jul - Sep;11(3):215-220. doi: 10.1016/j.dsx.2016.08.007. Epub 2016 Aug 23. Review.

PMID:
27578620
13.

Data regarding association between serum osteoprotegerin level, numerous of circulating endothelial-derived and mononuclear-derived progenitor cells in patients with metabolic syndrome.

Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV, Gronenko EA.

Data Brief. 2016 Jun 29;8:717-22. doi: 10.1016/j.dib.2016.06.015. eCollection 2016 Sep.

14.

The pattern of circulating microparticles in patients with diabetes mellitus with asymptomatic atherosclerosis.

Berezin AE, Kremzer AA, Berezina TA, Martovitskaya YV.

Acta Clin Belg. 2016 Feb;71(1):38-45. doi: 10.1080/17843286.2015.1110894. Epub 2016 Feb 3.

PMID:
27075791
15.

Predictive value of circulating osteonectin in patients with ischemic symptomatic chronic heart failure.

Berezin AE, Kremzer AA.

Biomed J. 2015 Dec;38(6):523-30. doi: 10.1016/j.bj.2015.08.002. Epub 2016 Feb 19.

16.

Pattern of endothelial progenitor cells and apoptotic endothelial cell-derived microparticles in chronic heart failure patients with preserved and reduced left ventricular ejection fraction.

Berezin AE, Kremzer AA, Martovitskaya YV, Berezina TA, Gromenko EA.

EBioMedicine. 2016 Jan 20;4:86-94. doi: 10.1016/j.ebiom.2016.01.018. eCollection 2016 Feb.

17.

Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.

Berezin AE.

J Circ Biomark. 2016 Mar 16;5:6. doi: 10.5772/62797. eCollection 2016 Jan-Dec. Review.

18.

Stable Coronary Artery Disease Patients: Different Practice Patterns in Everyday Clinical Situations.

Berezin AE.

EBioMedicine. 2015 Oct 9;2(11):1576. doi: 10.1016/j.ebiom.2015.10.007. eCollection 2015 Nov. No abstract available.

19.

The utility of biomarker risk prediction score in patients with chronic heart failure.

Berezin AE, Kremzer AA, Martovitskaya YV, Samura TA, Berezina TA, Zulli A, Klimas J, Kruzliak P.

Int J Clin Exp Med. 2015 Oct 15;8(10):18255-64. eCollection 2015.

20.

Supplemental Content

Loading ...
Support Center